Heparanase as a molecular target of cancer chemotherapy

Cancer Science

Volumn 95, Issue 7, 2004, Pages 553-558

  Simizu, Siro ^a   Ishida, Keisuke ^a,b   Osada, Hiroyuki ^a  

^a Japan Science and Technology Agency   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

A 72363C; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; AZAPSEUDODISACCHARIDE; BETA GLUCURONIDASE; ENZYME INHIBITOR; GEMDIAMINE 1 N IMINOSUGAR; GLYCOSIDASE; HEPARAN SULFATE; HEPARANASE; HEPARIN; HEPARINASE INHIBITOR; KI 105; MESSENGER RNA; OLIGOSACCHARIDE; PHOSPHOMANNOPENTAOSE SULFATE; PI 88; PROTEINASE; RK 682; SURAMIN; TRACHYSPIC ACID; UNCLASSIFIED DRUG;

CANCER CELL; CANCER CHEMOTHERAPY; CANCER INVASION; CELL TRANSFORMATION; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG RESEARCH; DRUG SCREENING; DRUG TARGETING; ENZYMATIC DEGRADATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SPECIFICITY; ESOPHAGUS CARCINOMA; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE OVEREXPRESSION; HEAD AND NECK TUMOR; HUMAN; IC 50; LIVER CELL CARCINOMA; METASTASIS; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION; TUMOR CELL;

ENZYME INHIBITORS; EXTRACELLULAR MATRIX; GLUCURONIDASE; HUMANS; NEOPLASMS; RNA;

EID: 4143083982     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2004.tb02485.x     Document Type: Review

References (49)

1. Turnbull J, Powell A, Guimond S. Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol 2001; 11: 75-82.
2. Esko JD, Selleck SB. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 2002; 71: 435-71.
3. Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68: 729-77.
4. Yu W-H, Woessner JF Jr. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem 2000; 275: 4183-91.
5. Dempsey LA, Brunn GJ, Platt JL. Heparanase, a potential regulator of cell-matrix interactions. Trends Biochem Sci 2000; 25: 349-51.
6. Vlodavsky I, Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 2001; 108: 341-7.
7. Bame KJ. Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans. Glycobiology 2001; 11: 91R-8R.
8. Parish CR, Freeman C, Hulett MD. Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 2001; 1471: M99-108.
9. Höök M, Wasteson Å, Oldberg Å. A heparan sulfate-degrading endoglycosidase from rat liver tissue. Biochem Biophys Res Commun 1975; 67: 1422-8.
10. Nakajima M, Irimura T, Di Ferrante D, Di Ferrante N, Nicolson GL. Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science 1983; 220: 611-3.
11. Nakajima M, Irimura T, Di Ferrante N, Nicolson GL. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J Biol Chem 1984; 259: 2283-90.
12. Toyoshima M, Nakajima M. Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem 1999; 274: 24153-60.
13. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L, Peckers I. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 1999; 5: 793-802.
14. Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, Parish CR. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 1999; 5: 803-9.
15. Fairbanks MB, Mildner AM, Leone JW, Cavey GS, Mathews WR, Drong RF, Slightom JL, Bienkowski MJ, Smith CW, Bannow CA, Heinrikson RL. Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer. J Biol Chem 1999; 274: 29587-90.
16. Kussie PH, Hulmes JD, Ludwig DL, Patel S, Navarro EC, Seddon AP, Giorgio NA, Bohlen P. Cloning and functional expression of a human heparanase gene. Biochem Biophys Res Commun 1999; 261: 183-7.
17. Simizu S, Ishida K, Wierzba MK, Sato TA, Osada H. Expression of heparanase in human tumor cell lines and human head and neck tumors. Cancer Lett 2003; 193: 83-9.
18. Koliopanos A, Friess H, Kleeff J, Shi X, Liao Q, Pecker I, Vlodavsky I, Zimmermann A, Büchler MW. Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res 2001; 61: 4655-9.
19. El-Assal ON, Yamanoi A, Ono T, Kohno H, Nagasue N. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma. Clin Cancer Res 2001; 7: 1299-305.
20. Mikami S, Ohashi K, Usui Y, Nemoto T, Katsube K, Yanagishita M, Nakajima M, Nakamura K, Koike M. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas. Jpn J Cancer Res 2001; 92: 1062-73.
21. Shteper PJ, Zcharia E, Ashhab Y, Peretz T, Vlodavsky I, Ben-Yehuda D. Role of promoter methylation in regulation of the mammalian heparanase gene. Oncogene 2003; 22: 7737-49.
22. McKenzie E, Young K, Hircock M, Bennett J, Bhaman M, Felix R, Turner P, Stamp A, Mcmillan D, Saville G, Ng S, Mason S, Snell D, Schofield D, Gong H, Townsend R, Gallagher J, Parekh R, Stubberfield C. Biochemical characterization of active heterodimer form of human heparanase (Hpa1) protein expression expressed in insect cells. Biochem J 2003; 373: 423-35.
23. Levy-Adam F, Miao H-Q, Heinrikson RL, Vlodavsky I, Ilan N. Heterodimer formation is essential for heparanase enzymatic activity. Biochem Biophys Res Commun 2003; 308: 885-91.
24. Simizu S, Ishida K, Wierzba MK, Osada H. Secretion of heparanase protein is regulated by glycosylation in human tumor cell lines. J Biol Chem 2004; 279: 2697-703.
25. Goldshmidt O, Zcharia E, Aingorn H, Guatta-Rangini Z, Atzmon R, Michal I, Pecker I, Mitrani E, Vlodavsky I. Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence. J Biol Chem 2001; 276: 29178-87.
26. Goldshmidt O, Zcharia E, Abramovitch R, Metzger S, Aingorn H, Friedmann Y, Schirrmacher V, Mitrani E, Vlodavsky I. Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc Natl Acad Sci USA 2002; 99: 10031-6.
27. Nadav L, Eldor A, Yacoby-Zeevi O, Zamir E, Pecker I, Ilan N, Geiger B, Vlodavsky I, Katz B-Z. Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts. J Cell Sci 2002; 115: 2179-87.
28. Hulett MD, Hornby JR, Ohms SJ, Zuegg J, Freeman C, Gready JE, Parish CR. Identification of active-site residues of the pro-metastatic endoglycosidase heparanase. Biochemistry 2000; 39: 15659-67.
29. Davies G, Henrissat B. Structures and mechanisms of glycosyl hydrolases. Structure 1995; 15: 853-9.
30. Ishida K, Wierzba MK, Teruya T, Simizu S, Osada H. Novel heparan sulfate mimetic compounds as antitumor agents. Chem Biol 2004; 11: 367-77.
31. Zcharia E, Metzger S, Chajek-Shaul T, Aingorn H, Elkin M, Friedmann Y, Weinstein T, Li J-P, Lindahl U, Vlodavsky I. Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior. FASEB J 2004; 18: 252-63.
32. McKenzie E, Tyson K, Stamps A, Smith P, Turner P, Barry R, Hircock M, Patel S, Barry E, Stubberfield C, Terrett J, Page M. Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochem Biophys Res Commun 2000; 276: 1170-7.
33. Jiang P, Kumar A, Parrillo JE, Dempsey LA, Platt JL, Prinz RA, Xu X. Cloning and characterization of the human heparanase-1 (HPR1) gene promoter. Role of GA-binding protein and Sp1 in regulating HPR1 basal promoter activity. J Biol Chem 2002; 277: 8989-98.
34. Lu WC, Liu YN, Kang BB, Chen JH. Trans-activation of heparanase promoter by ETS transcription factors. Oncogene 2003; 22: 919-23.
35. Elkin M, Cohen I, Zcharia E, Orgel A, Guatta-Rangini Z, Peretz T, Vlodavsky I, Kleinman HK. Regulation of heparanase gene expression by estrogen in breast cancer. Cancer Res 2003; 63: 8821-6.
36. de Mestre AM, Khachigian LM, Santiago FS, Staykova MA, Hulett MD. Regulation of inducible heparanase gene transcription in activated T cells by early growth response 1. J Biol Chem 2003; 278: 50377-85.
37. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986; 321: 209-13.
38. Toyota M, Issa J-P. CpG island methylator phenotypes in aging and cancer. Semin Cancer Biol 1999; 9: 349-57.
39. Uno F, Fijiwara T, Takata Y, Ohtani S, Katsuda K, Takaoka M, Ohkawa T, Naomoto Y, Nakajima M, Tanaka N. Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells. Cancer Res 2001; 61: 7855-60.
40. Parish CR, Freeman C, Brown KJ, Francis DJ, Cowden WB. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for anigiogenesis and heparanase activity. Cancer Res 1999; 59: 3433-41.
41. Ishida K, Teruya T, Simizu S, Osada H. Exploitation of heparanase inhibitors from microbial metabolites using an efficient visual screening system. J Antibiot (Tokyo) 2004; 57: 136-42.
42. Usui T, Kojima S, Kidokoro S, Ueda K, Osada H, Sodeoka M. Design and synthesis of a dimeric derivative of RK-682 with increased inhibitory activity against VHR, a dual-specificity ERK phosphatase: implications for the molecular mechanism of the inhibition. Chem Biol 2001; 8: 1209-20.
43. Ishida K, Hirai G, Murakami K, Teruya T, Simizu S, Sodeoka M, Osada H. Rational drug design of a selective heparanase inhibitor as antimetastatic agent. Mol Cancer Ther 2004; 3: revised.
44. Nakajima M, DeChavigny A, Johnson CE, Hamada J, Stein CA, Nicolson GL. Suramin. A potent inhibitor of melanoma heparanase and invasion. J Biol Chem 1991; 266: 9661-6.
45. Shiozawa H, Takahashi M, Takatsu T, Kinoshita T, Tanzawa K, Hosoya T, Furuya K, Takahashi S, Furihata K, Seto H. Trachyspic acid, a new metabolite produced by Talaromyces trachyspermus, that inhibits tumor cell heparanase: taxonomy of the producing strain, fermentation, isolation, structural elucidation, and biological activity. J Antibiot (Tokyo) 1995; 48: 357-62.
46. Okada Y, Yamada S, Toyoshima M, Dong J, Nakajima M, Sugahara K. Structure recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with differential effects and the essential target disulfated trisaccharide sequence. J Biol Chem 2002; 277: 42488-95.
47. Takahashi S, Kuzuhara H, Nakajima M. Design and synthesis of a heparanase inhibitor with pseudodisaccharide structure. Tetrahedron 2001; 57: 6915-26.
48. Nishimura Y, Shitara E, Adachi H, Toyoshima M, Nakajima M, Okami Y, Takeuchi T. Flexible synthesis and biological activity of uronic acid-type gem-diamine 1-N-iminosugars: a new family of glycosidase inhibitors. J Org Chem 2000; 65: 2-11.
49. Kawase Y, Takahashi M, Takatsu T, Arai M, Nakajima M, Tanzawa K. A-72363 A-1, A-2 and C, novel heparanase inhibitors from Streptomyces nobilis SANK 60192. II. Biological activity. J Antibiot (Tokyo) 1996; 49: 61-4.